World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
64
Citations
20598
World Ranking
1711
National Ranking
29

Radek C. Skoda publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Radek C. Skoda sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 158 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Radek C. Skoda D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Radek C. Skoda sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 64 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Radek C. Skoda is affiliated with the University Hospital of Basel in Switzerland. Their research focuses primarily on medicine, with a significant concentration in hematology and genetics, complemented by work in molecular biology, rheumatology, and oncology.

The scientist's recent publications cover a range of topics within hematological cancers and molecular mechanisms. Key papers include:

  • "Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia," 2022, Blood
  • "Genetic basis and molecular profiling in myeloproliferative neoplasms," 2022, Blood
  • "Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation," 2020, Blood
  • "JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality," 2021, Blood
  • "Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm," 2022, Nature Communications

Skoda's work addresses critical areas such as myeloproliferative neoplasms and acute myeloid leukemia, which are reflected in their main topics of research:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Kruppel-like factors research
  • Eosinophilic Disorders and Syndromes
  • Cytokine Signaling Pathways and Interactions
  • Hemoglobinopathies and Related Disorders

Frequent publication venues include journals that specialize in hematology and related biomedical sciences, notably:

  • Blood (18 publications)
  • HemaSphere (5 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (4 publications)
  • Blood Advances (3 publications)
  • Nature Communications (2 publications)

Collaboration plays a significant role in Skoda's research output, with numerous co-authors contributing to their work. Among the most frequent collaborators are:

  • Hui Hao-Shen (19 joint publications)
  • Shivam Rai (14 joint publications)
  • Marc Usart (14 joint publications)
  • Jan Stetka (13 joint publications)
  • Nils Hansen (10 joint publications)

Overall, Radek C. Skoda's scientific contributions intersect the genetic and molecular bases of hematological diseases, contributing to the understanding and potential treatment strategies for myeloproliferative and leukemic conditions.

Best Publications

  • Defective STAT signaling by the leptin receptor in diabetic mice.

    Nico Ghilardi;Sandra Ziegler;Adrian Wiestner;Ruedi Stoffel

  • Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.

    F J Gonzalez;R C Skoda;S Kimura;M Umeno

  • Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

    Pontus Lundberg;Axel Karow;Ronny Nienhold;Renate Looser

  • The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.

    S Kimura;M Umeno;R C Skoda;U A Meyer

  • Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo

    Unknown

  • The Leptin Receptor Activates Janus Kinase 2 and Signals for Proliferation in a Factor-Dependent Cell Line

    Nico Ghilardi;Radek C. Skoda

  • Platelets regulate lymphatic vascular development through CLEC-2–SLP-76 signaling

    Cara C. Bertozzi;Alec A. Schmaier;Patricia Mericko;Paul R. Hess

  • Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms

    Lorena Arranz;Abel Sánchez-Aguilera;Daniel Martín-Pérez;Joan Isern

  • Leukemic blasts in transformed JAK2-V617F –positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

    Alexandre Theocharides;Marjorie Boissinot;François Girodon;Richard Garand

  • Talin is required for integrin-mediated platelet function in hemostasis and thrombosis

    Brian G. Petrich;Patrizia Marchese;Zaverio M. Ruggeri;Saskia Spiess

  • Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders

    Unknown

  • The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera

    Unknown

  • The Pseudokinase Domain of JAK2 Is a Dual-Specificity Protein Kinase That Negatively Regulates Cytokine Signaling

    Daniela Ungureanu;Jinhua Wu;Jinhua Wu;Tuija Pekkala;Yashavanthi Niranjan

  • Two mutant alleles of the human cytochrome P-450db1 gene (P450C2D1) associated with genetically deficient metabolism of debrisoquine and other drugs.

    Radek C. Skoda;Frank J. Gonzalez;Anne Demierre;Urs A. Meyer

  • Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2.

    Robert Kralovics;Soon Siong Teo;Soon Siong Teo;Andreas S. Buser;Andreas S. Buser;Martin Brutsche;Martin Brutsche

  • Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion

    Catherine Léon;Anita Eckly;Béatrice Hechler;Boris Aleil

  • Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal.

    R. C. Skoda;D. C. Seldin;Ming-Ko Chiang;C. L. Peichel

  • Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms.

    Franz X. Schaub;Renate Looser;Sai Li;Hui Hao-Shen

  • The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms.

    Urs A. Meyer;Radek C. Skoda;Ulrich M. Zanger

  • Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene

    Nico Ghilardi;Adrian Wiestner;Masahiro Kikuchi;Akimichi Ohsaka

Frequent Co-Authors

André Tichelli
André Tichelli University Hospital of Basel
Jakob Passweg
Jakob Passweg University Hospital of Basel
Mario Cazzola
Mario Cazzola University of Pavia
Nico Ghilardi
Nico Ghilardi Genentech
Markus G. Manz
Markus G. Manz University of Zurich
Francesco Passamonti
Francesco Passamonti University of Milan
Daniela Pietra
Daniela Pietra University of Pavia
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Stuart H. Orkin
Stuart H. Orkin Harvard University
Josef T. Prchal
Josef T. Prchal University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your studies beyond molecular biology can open diverse career options in health, education, or counseling. For those seeking education flexibility or needing to balance military service, several online colleges for military offer tailored support and resources, making it easier for service members and veterans to complete their degrees.

If you're interested in applying your science background to mental health or social services, consider earning a degree in social work or psychology. Accredited online msw programs prepare students for impactful roles in diverse community settings. Additionally, fast track masters in psychology programs allow you to accelerate your studies and enter the workforce more quickly.

For those passionate about supporting mental well-being, there are also online masters mental health counseling options that combine advanced coursework with flexible scheduling. Exploring these related pathways can help broaden your impact and increase your career versatility within the wider health sciences field.

Best Scientists Citing Radek C. Skoda

Trending Scientists

Recently Published Articles